References
- Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med. 1986;314(12):736–739. DOI:https://doi.org/10.1056/NEJM198603203141202
- Shin MS, Ho KJ. Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence? Chest. 1993;104(5):1384–1386. DOI:https://doi.org/10.1378/chest.104.5.1384
- Mahr AD, Edberg JC, Stone JH, et al. Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener’s granulomatosis. Arthritis Rheum. 2010;62(12):3760–3767. DOI:https://doi.org/10.1002/art.27742
- Smith KC, Pittelkow MR, Su WP. Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature. Arch Dermatol. 1987;123(12):1655–1661.
- Yang P, Tremaine WJ, Meyer RL, et al. Alpha1-antitrypsin deficiency and inflammatory bowel diseases. Mayo Clin Proc. 2000;75(5):450–455.
- Institute NHLaB. Alpha-1 Antitrypsin deficiency. Published 2019. Available from: https://www.nhlbi.nih.gov/health-topics/alpha-1-antitrypsin-deficiency.
- Zacherle EN, Runken MC, Blanchette CM. Health care cost and utilization associated with alpha-1 antitrypsin deficiency among a cohort of medicare beneficiaries with COPD. Value Health. 2015;18(7):A664.
- Beiko T, Strange C. Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life. Ther Clin Risk Manag. 2019;15:959–964. DOI:https://doi.org/10.2147/TCRM.S175369
- Matte DL, Pizzichini MM, Hoepers AT, et al. Prevalence of depression in COPD: a systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154–161. DOI:https://doi.org/10.1016/j.rmed.2016.06.006
- Doyle T, Palmer S, Johnson J, et al. Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. Int J Psychiatry Med. 2013;45(2):189–202. DOI:https://doi.org/10.2190/PM.45.2.g
- Yohannes AM, Willgoss TG, Baldwin RC, et al. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–1221. DOI:https://doi.org/10.1002/gps.2463
- Dalal AA, Shah M, Lunacsek O, et al. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. Copd. 2011;8(4):293–299. DOI:https://doi.org/10.3109/15412555.2011.586659
- Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349. DOI:https://doi.org/10.1183/09059180.00007813
- Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5):858–866.
- Ketelaars CA, Schlosser MA, Mostert R, et al. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax. 1996;51(1):39–43. DOI:https://doi.org/10.1136/thx.51.1.39
- Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol. 1988;41(3):251–260. DOI:https://doi.org/10.1016/0895-4356(88)90129-1
- Tockman MS, Comstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington county, Maryland. Am Rev Respir Dis. 1989;140(3 Pt 2):S56–S63. DOI:https://doi.org/10.1164/ajrccm/140.3_Pt_2.S56
- Stockley RA, Edgar RG, Pillai A, et al. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management? COPD. 2016;11:1745–1756. DOI:https://doi.org/10.2147/COPD.S111508
- Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med. 2006;174(8):886–893. DOI:https://doi.org/10.1164/rccm.200509-1374OC
- Green CE, Vayalapra S, Hampson JA, et al. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD. Thorax. 2015;70(10):939–945. DOI:https://doi.org/10.1136/thoraxjnl-2015-206906
- Pillai AP, Turner AM, Stockley RA. Relationship of the 2011 global initiative for chronic obstructive lung disease strategy to clinically relevant outcomes in individuals with alpha1-antitrypsin deficiency. Annals Ats. 2014;11(6):859–864. DOI:https://doi.org/10.1513/AnnalsATS.201311-380OC
- Stockley RA, Miravitlles M, Vogelmeier C, et al. Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach. Orphanet J Rare Dis. 2013;8:149. DOI:https://doi.org/10.1186/1750-1172-8-149
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. DOI:https://doi.org/10.1016/0021-9681(87)90171-8
- Sundararajan V, Henderson T, Perry C, et al. New ICD-10 version of the charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12):1288–1294. DOI:https://doi.org/10.1016/j.jclinepi.2004.03.012
- Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. DOI:https://doi.org/10.1378/chest.93.3.580
- RA S. Proteases and antiproteases in chronic obstructive pulmonary disease: Pathogenesis to treatment. Chisester (UK): Wiley; 2001.
- Park Y, Jung JY, Kim YS, et al. Relationship between depression and lung function in the general population in Korea: a retrospective cross-sectional study. COPD. 2018;13:2207–2213. DOI:https://doi.org/10.2147/COPD.S169025
- Lara B, Miravitlles M. Spanish registry of patients with alpha-1 antitrypsin deficiency; comparison of the characteristics of PISZ and PIZZ individuals. COPD. 2015;12 Suppl 1:27–31. DOI:https://doi.org/10.3109/15412555.2015.1021912
- Hajiro T, Nishimura K, Tsukino M, et al. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):841–846. DOI:https://doi.org/10.1053/rmed.2000.0804
- Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87–93. DOI:https://doi.org/10.1016/j.rmed.2005.04.003
- Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of pearson correlations. Prim Care Respir J. 2011;20(3):257–268. DOI:https://doi.org/10.4104/pcrj.2011.00029
- Hynninen MJ, Pallesen S, Nordhus IH. Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis. 2007;2(3):323–328.
- Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. DOI:https://doi.org/10.1097/00005650-199206000-00002
- Hobbins S, Chapple IL, Sapey E, et al. Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors? Int J Chron Obstruct Pulmon Dis. 2017;12:1339–1349. DOI:https://doi.org/10.2147/COPD.S127802
- Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264(12):1546–1549.
- Glassman AH, Covey LS, Stetner F, et al. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357(9272):1929–1932. DOI:https://doi.org/10.1016/S0140-6736(00)05064-9
- Goodwin RD, Lavoie KL, Lemeshow AR, et al. Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res. 2012;14(2):176–183. DOI:https://doi.org/10.1093/ntr/ntr165
- Dowson C, Laing R, Barraclough R, et al. The use of the hospital anxiety and depression scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J. 2001. 114(1141):447–449.
- Stage KB, Middelboe T, Pisinger C. Measurement of depression in patients with chronic obstructive pulmonary disease (COPD). Nord J Psychiatry. 2003;57(4):297–301. DOI:https://doi.org/10.1080/08039480310002147
- Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriat Psychiatry. 2000;15(12):1090–1096. DOI:https://doi.org/10.1002/1099-1166(200012)15:12<1090::AID-GPS249>3.0.CO;2-L
- Mignogna J, Cully J. Depression and anxiety in patients with COPD: a focus on psychological treatments in ambulatory care settings. Curr. Respir. Med. Rev. 2012;8:137–144.
- Tselebis A, Pachi A, Ilias I, et al. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat. 2016;12:297–328. DOI:https://doi.org/10.2147/NDT.S79354